{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T16:35:13Z","timestamp":1788885313224,"version":"build-2803163510"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,16]],"date-time":"2020-03-16T00:00:00Z","timestamp":1584316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,16]],"date-time":"2020-03-16T00:00:00Z","timestamp":1584316800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Leukaemogenic mutations commonly disrupt cellular differentiation and\/or enhance proliferation, thus perturbing the regulatory programs that control self-renewal and differentiation of stem and progenitor cells. Translocations involving the<jats:italic>Mll1<\/jats:italic>(<jats:italic>Kmt2a<\/jats:italic>) gene generate powerful oncogenic fusion proteins, predominantly affecting infant and paediatric AML and ALL patients. The early stages of leukaemogenic transformation are typically inaccessible from human patients and conventional mouse models. Here, we take advantage of cells conditionally blocked at the multipotent haematopoietic progenitor stage to develop a MLL-r model capturing early cellular and molecular consequences of MLL-ENL expression based on a clear clonal relationship between parental and leukaemic cells. Through a combination of scRNA-seq, ATAC-seq and genome-scale CRISPR-Cas9 screening, we identify pathways and genes likely to drive the early phases of leukaemogenesis. Finally, we demonstrate the broad utility of using matched parental and transformed cells for small molecule inhibitor studies by validating both previously known and other potential therapeutic targets.<\/jats:p>","DOI":"10.1038\/s41467-020-15220-0","type":"journal-article","created":{"date-parts":[[2020,3,16]],"date-time":"2020-03-16T11:05:42Z","timestamp":1584356742000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Dissecting the early steps of MLL induced leukaemogenic transformation using a mouse model of AML"],"prefix":"10.1038","volume":"11","author":[{"given":"Silvia","family":"Basilico","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3759-778X","authenticated-orcid":false,"given":"Xiaonan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6681-3256","authenticated-orcid":false,"given":"Alison","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4865-7648","authenticated-orcid":false,"given":"Konstantinos","family":"Tzelepis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1390-6592","authenticated-orcid":false,"given":"George","family":"Giotopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J.","family":"Kinston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7793-6291","authenticated-orcid":false,"given":"Pedro M.","family":"Quiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0984-1477","authenticated-orcid":false,"given":"Kim","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9490-0306","authenticated-orcid":false,"given":"David J.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7432-0195","authenticated-orcid":false,"given":"Larissa S.","family":"Carnevalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0312-161X","authenticated-orcid":false,"given":"Brian J. P.","family":"Huntly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4337-8022","authenticated-orcid":false,"given":"George S.","family":"Vassiliou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3358-8253","authenticated-orcid":false,"given":"Fernando J.","family":"Calero-Nieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6302-5705","authenticated-orcid":false,"given":"Berthold","family":"G\u00f6ttgens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,16]]},"reference":[{"key":"15220_CR1","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/leu.2017.213","volume":"32","author":"C Meyer","year":"2018","unstructured":"Meyer, C. et al. The MLL recombinome of acute leukemias in 2017. Leukemia 32, 273\u2013284 (2018).","journal-title":"Leukemia"},{"key":"15220_CR2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1182\/blood.V96.1.24","volume":"96","author":"A Biondi","year":"2000","unstructured":"Biondi, A., Cimino, G., Pieters, R. & Pui, C. H. Biological and therapeutic aspects of infant leukemia. Blood 96, 24\u201333 (2000).","journal-title":"Blood"},{"key":"15220_CR3","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/sj.leu.2404598","volume":"21","author":"CH Pui","year":"2007","unstructured":"Pui, C. H. & Campana, D. Age-related differences in leukemia biology and prognosis: the paradigm of MLL-AF4-positive acute lymphoblastic leukemia. Leukemia 21, 593\u2013594 (2007).","journal-title":"Leukemia"},{"key":"15220_CR4","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0167-4781(98)00139-0","volume":"1400","author":"CA Felix","year":"1998","unstructured":"Felix, C. A. Secondary leukemias induced by topoisomerase-targeted drugs. Biochim. Biophys. Acta 1400, 233\u2013255 (1998).","journal-title":"Biochim. Biophys. Acta"},{"key":"15220_CR5","doi-asserted-by":"publisher","first-page":"4226","DOI":"10.1093\/emboj\/16.14.4226","volume":"16","author":"C Lavau","year":"1997","unstructured":"Lavau, C., Szilvassy, S. J., Slany, R. & Cleary, M. L. Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL. EMBO J. 16, 4226\u20134237 (1997).","journal-title":"EMBO J."},{"key":"15220_CR6","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.ccr.2008.03.005","volume":"13","author":"W Chen","year":"2008","unstructured":"Chen, W. et al. Malignant transformation initiated by Mll-AF9: gene dosage and critical target cells. Cancer Cell 13, 432\u2013440 (2008).","journal-title":"Cancer Cell"},{"key":"15220_CR7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ccell.2016.05.011","volume":"30","author":"V Stavropoulou","year":"2016","unstructured":"Stavropoulou, V. et al. MLL-AF9 expression in hematopoietic stem cells drives a highly invasive AML expressing EMT-related genes linked to poor outcome. Cancer Cell 30, 43\u201358 (2016).","journal-title":"Cancer Cell"},{"key":"15220_CR8","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/leu.2012.363","volume":"27","author":"AV Krivtsov","year":"2013","unstructured":"Krivtsov, A. V. et al. Cell of origin determines clinically relevant subtypes of MLL-rearranged AML. Leukemia 27, 852\u2013860 (2013).","journal-title":"Leukemia"},{"key":"15220_CR9","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.celrep.2014.10.036","volume":"9","author":"A Ugale","year":"2014","unstructured":"Ugale, A. et al. Hematopoietic stem cells are intrinsically protected against MLL-ENL-mediated transformation. Cell Rep. 9, 1246\u20131255 (2014).","journal-title":"Cell Rep."},{"key":"15220_CR10","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1016\/j.cell.2015.11.013","volume":"163","author":"F Paul","year":"2015","unstructured":"Paul, F. et al. Transcriptional heterogeneity and lineage commitment in myeloid progenitors. Cell 163, 1663\u20131677 (2015).","journal-title":"Cell"},{"key":"15220_CR11","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1016\/j.cell.2015.11.059","volume":"163","author":"L Perie","year":"2015","unstructured":"Perie, L., Duffy, K. R., Kok, L., de Boer, R. J. & Schumacher, T. N. The branching point in erythro-myeloid differentiation. Cell 163, 1655\u20131662 (2015).","journal-title":"Cell"},{"key":"15220_CR12","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1126\/science.1201219","volume":"333","author":"F Notta","year":"2011","unstructured":"Notta, F. et al. Isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment. Science 333, 218\u2013221 (2011).","journal-title":"Science"},{"key":"15220_CR13","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.cell.2008.10.048","volume":"135","author":"A Wilson","year":"2008","unstructured":"Wilson, A. et al. Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell 135, 1118\u20131129 (2008).","journal-title":"Cell"},{"key":"15220_CR14","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1101\/gad.8.23.2831","volume":"8","author":"S Tsai","year":"1994","unstructured":"Tsai, S., Bartelmez, S., Sitnicka, E. & Collins, S. Lymphohematopoietic progenitors immortalized by a retroviral vector harboring a dominant-negative retinoic acid receptor can recapitulate lymphoid, myeloid, and erythroid development. Genes Dev. 8, 2831\u20132841 (1994).","journal-title":"Genes Dev."},{"key":"15220_CR15","doi-asserted-by":"publisher","first-page":"5744","DOI":"10.1093\/emboj\/17.19.5744","volume":"17","author":"OP Pinto do","year":"1998","unstructured":"Pinto do, O. P., Kolterud, A. & Carlsson, L. Expression of the LIM-homeobox gene LH2 generates immortalized steel factor-dependent multipotent hematopoietic precursors. EMBO J. 17, 5744\u20135756 (1998).","journal-title":"EMBO J."},{"key":"15220_CR16","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/nmeth.2510","volume":"10","author":"V Redecke","year":"2013","unstructured":"Redecke, V. et al. Hematopoietic progenitor cell lines with myeloid and lymphoid potential. Nat. Methods 10, 795\u2013803 (2013).","journal-title":"Nat. Methods"},{"key":"15220_CR17","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.stem.2015.04.004","volume":"16","author":"NK Wilson","year":"2015","unstructured":"Wilson, N. K. et al. Combined single-cell functional and gene expression analysis resolves heterogeneity within stem cell populations. Cell Stem Cell 16, 712\u2013724 (2015).","journal-title":"ell Stem Cell"},{"key":"15220_CR18","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/nature04980","volume":"442","author":"AV Krivtsov","year":"2006","unstructured":"Krivtsov, A. V. et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature 442, 818\u2013822 (2006).","journal-title":"Nature"},{"key":"15220_CR19","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1101\/gad.1143403","volume":"17","author":"A Cozzio","year":"2003","unstructured":"Cozzio, A. et al. Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. Genes Dev. 17, 3029\u20133035 (2003).","journal-title":"Genes Dev."},{"key":"15220_CR20","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/nprot.2014.006","volume":"9","author":"S Picelli","year":"2014","unstructured":"Picelli, S. et al. Full-length RNA-seq from single cells using Smart-seq2. Nat. Protoc. 9, 171\u2013181 (2014).","journal-title":"Nat. Protoc."},{"key":"15220_CR21","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/nature19348","volume":"537","author":"A Olsson","year":"2016","unstructured":"Olsson, A. et al. Single-cell analysis of mixed-lineage states leading to a binary cell fate choice. Nature 537, 698\u2013702 (2016).","journal-title":"Nature"},{"key":"15220_CR22","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.4049\/jimmunol.152.4.1836","volume":"152","author":"CJ Czuprynski","year":"1994","unstructured":"Czuprynski, C. J., Brown, J. F., Maroushek, N., Wagner, R. D. & Steinberg, H. Administration of anti-granulocyte mAb RB6-8C5 impairs the resistance of mice to Listeria monocytogenes infection. J. Immunol. 152, 1836\u20131846 (1994).","journal-title":"J. Immunol."},{"key":"15220_CR23","doi-asserted-by":"publisher","first-page":"6895","DOI":"10.1182\/blood-2010-12-324699","volume":"117","author":"QF Wang","year":"2011","unstructured":"Wang, Q. F. et al. MLL fusion proteins preferentially regulate a subset of wild-type MLL target genes in the leukemic genome. Blood 117, 6895\u20136905 (2011).","journal-title":"Blood"},{"key":"15220_CR24","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1182\/blood-2017-12-821413","volume":"131","author":"JS Dahlin","year":"2018","unstructured":"Dahlin, J. S. et al. A single-cell hematopoietic landscape resolves 8 lineage trajectories and defects in Kit mutant mice. Blood 131, e1\u2013e11 (2018).","journal-title":"Blood"},{"key":"15220_CR25","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1128\/MCB.24.2.617-628.2004","volume":"24","author":"BB Zeisig","year":"2004","unstructured":"Zeisig, B. B. et al. Hoxa9 and Meis1 are key targets for MLL-ENL-mediated cellular immortalization. Mol. Cell. Biol. 24, 617\u2013628 (2004).","journal-title":"Mol. Cell. Biol."},{"key":"15220_CR26","first-page":"6480","volume":"61","author":"S Schreiner","year":"2001","unstructured":"Schreiner, S. et al. MLL-ENL causes a reversible and myc-dependent block of myelomonocytic cell differentiation. Cancer Res. 61, 6480\u20136486 (2001).","journal-title":"Cancer Res."},{"key":"15220_CR27","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1182\/blood.V97.8.2449","volume":"97","author":"PG Lutz","year":"2001","unstructured":"Lutz, P. G., Houzel-Charavel, A., Moog-Lutz, C. & Cayre, Y. E. Myeloblastin is an Myb target gene: mechanisms of regulation in myeloid leukemia cells growth-arrested by retinoic acid. Blood 97, 2449\u20132456 (2001).","journal-title":"Blood"},{"key":"15220_CR28","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/nmeth.2688","volume":"10","author":"JD Buenrostro","year":"2013","unstructured":"Buenrostro, J. D., Giresi, P. G., Zaba, L. C., Chang, H. Y. & Greenleaf, W. J. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat. Methods 10, 1213\u20131218 (2013).","journal-title":"Nat. Methods"},{"key":"15220_CR29","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.stem.2015.08.011","volume":"17","author":"M Ye","year":"2015","unstructured":"Ye, M. et al. Hematopoietic differentiation is required for initiation of acute myeloid leukemia. Cell Stem Cell 17, 611\u2013623 (2015).","journal-title":"Cell Stem Cell"},{"key":"15220_CR30","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1146\/annurev-immunol-032713-120204","volume":"34","author":"TL Murphy","year":"2016","unstructured":"Murphy, T. L. et al. Transcriptional control of dendritic cell development. Annu. Rev. Immunol. 34, 93\u2013119 (2016).","journal-title":"Annu. Rev. Immunol."},{"key":"15220_CR31","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1084\/jem.20020045","volume":"195","author":"M Gilliet","year":"2002","unstructured":"Gilliet, M. et al. The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte\/macrophage colony-stimulating factor. J. Exp. Med. 195, 953\u2013958 (2002).","journal-title":"J. Exp. Med."},{"key":"15220_CR32","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1242\/dev.112.2.517","volume":"112","author":"L Morris","year":"1991","unstructured":"Morris, L., Graham, C. F. & Gordon, S. Macrophages in haemopoietic and other tissues of the developing mouse detected by the monoclonal antibody F4\/80. Development 112, 517\u2013526 (1991).","journal-title":"Development"},{"key":"15220_CR33","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1016\/S0301-472X(99)00106-X","volume":"27","author":"K Dannaeus","year":"1999","unstructured":"Dannaeus, K., Johannisson, A., Nilsson, K. & Jonsson, J. I. Flt3 ligand induces the outgrowth of Mac-1+B220+ mouse bone marrow progenitor cells restricted to macrophage differentiation that coexpress early B cell-associated genes. Exp. Hematol. 27, 1646\u20131654 (1999).","journal-title":"Exp. Hematol."},{"key":"15220_CR34","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1073\/pnas.0405193102","volume":"102","author":"D Lau","year":"2005","unstructured":"Lau, D. et al. Myeloperoxidase mediates neutrophil activation by association with CD11b\/CD18 integrins. Proc. Natl Acad. Sci. USA 102, 431\u2013436 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"15220_CR35","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1182\/blood.V93.3.849","volume":"93","author":"S Skold","year":"1999","unstructured":"Skold, S., Rosberg, B., Gullberg, U. & Olofsson, T. A secreted proform of neutrophil proteinase 3 regulates the proliferation of granulopoietic progenitor cells. Blood 93, 849\u2013856 (1999).","journal-title":"Blood"},{"key":"15220_CR36","first-page":"2438","volume":"118","author":"K Kessenbrock","year":"2008","unstructured":"Kessenbrock, K. et al. Proteinase 3 and neutrophil elastase enhance inflammation in mice by inactivating antiinflammatory progranulin. J. Clin. Investig. 118, 2438\u20132447 (2008).","journal-title":"J. Clin. Investig."},{"key":"15220_CR37","doi-asserted-by":"publisher","first-page":"6119","DOI":"10.4049\/jimmunol.173.10.6119","volume":"173","author":"CO Meyer zum Bueschenfelde","year":"2004","unstructured":"Meyer zum Bueschenfelde, C. O., Unternaehrer, J., Mellman, I. & Bottomly, K. Regulated recruitment of MHC class II and costimulatory molecules to lipid rafts in dendritic cells. J. Immunol. 173, 6119\u20136124 (2004).","journal-title":"J. Immunol."},{"key":"15220_CR38","doi-asserted-by":"publisher","first-page":"6936","DOI":"10.1073\/pnas.95.12.6936","volume":"95","author":"M Baumgart","year":"1998","unstructured":"Baumgart, M., Moos, V., Schuhbauer, D. & Muller, B. Differential expression of major histocompatibility complex class II genes on murine macrophages associated with T cell cytokine profile and protective\/suppressive effects. Proc. Natl Acad. Sci. USA 95, 6936\u20136940 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"15220_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-016-1176-5","volume":"17","author":"D DeTomaso","year":"2016","unstructured":"DeTomaso, D. & Yosef, N. FastProject: a tool for low-dimensional analysis of single-cell RNA-Seq data. BMC Bioinforma. 17, 315 (2016).","journal-title":"BMC Bioinforma."},{"key":"15220_CR40","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1126\/science.1218595","volume":"336","author":"M Jain","year":"2012","unstructured":"Jain, M. et al. Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation. Science 336, 1040\u20131044 (2012).","journal-title":"Science"},{"key":"15220_CR41","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1084\/jem.20151574","volume":"213","author":"Y Pikman","year":"2016","unstructured":"Pikman, Y. et al. Targeting MTHFD2 in acute myeloid leukemia. J. Exp. Med. 213, 1285\u20131306 (2016).","journal-title":"J. Exp. Med."},{"key":"15220_CR42","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.stem.2014.11.010","volume":"15","author":"C Bruedigam","year":"2014","unstructured":"Bruedigam, C. et al. Telomerase inhibition effectively targets mouse and human AML stem cells and delays relapse following chemotherapy. Cell Stem Cell 15, 775\u2013790 (2014).","journal-title":"Cell Stem Cell"},{"key":"15220_CR43","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.celrep.2016.09.079","volume":"17","author":"K Tzelepis","year":"2016","unstructured":"Tzelepis, K. et al. A CRISPR dropout screen identifies genetic vulnerabilities and therapeutic targets in acute myeloid leukemia. Cell Rep. 17, 1193\u20131205 (2016).","journal-title":"Cell Rep."},{"key":"15220_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0554-4","volume":"15","author":"W Li","year":"2014","unstructured":"Li, W. et al. MAGeCK enables robust identification of essential genes from genome-scale CRISPR\/Cas9 knockout screens. Genome Biol. 15, 554 (2014).","journal-title":"Genome Biol."},{"key":"15220_CR45","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.stem.2012.06.009","volume":"11","author":"D Kalaitzidis","year":"2012","unstructured":"Kalaitzidis, D. et al. mTOR complex 1 plays critical roles in hematopoiesis and Pten-loss-evoked leukemogenesis. Cell Stem Cell 11, 429\u2013439 (2012).","journal-title":"Cell Stem Cell"},{"key":"15220_CR46","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/nature04703","volume":"441","author":"OH Yilmaz","year":"2006","unstructured":"Yilmaz, O. H. et al. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 441, 475\u2013482 (2006).","journal-title":"Nature"},{"key":"15220_CR47","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3389\/fonc.2017.00098","volume":"7","author":"AB Herrero","year":"2017","unstructured":"Herrero, A. B., Gutierrez, N. C. & Targeting Ongoing, D. N. A. Damage in multiple myeloma: effects of DNA damage response inhibitors on plasma cell survival. Front. Oncol. 7, 98 (2017).","journal-title":"Front. Oncol."},{"key":"15220_CR48","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.ccr.2013.08.019","volume":"24","author":"HP Kuo","year":"2013","unstructured":"Kuo, H. P. et al. Epigenetic roles of MLL oncoproteins are dependent on NF-kappaB. Cancer Cell 24, 423\u2013437 (2013).","journal-title":"Cancer Cell"},{"key":"15220_CR49","doi-asserted-by":"publisher","first-page":"ra91","DOI":"10.1126\/scisignal.aad8243","volume":"9","author":"I Morgado-Palacin","year":"2016","unstructured":"Morgado-Palacin, I. et al. Targeting the kinase activities of ATR and ATM exhibits antitumoral activity in mouse models of MLL-rearranged AML. Sci. Signal. 9, ra91 (2016).","journal-title":"Sci. Signal."},{"key":"15220_CR50","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1038\/onc.2009.69","volume":"28","author":"S Boehrer","year":"2009","unstructured":"Boehrer, S. et al. Suppression of the DNA damage response in acute myeloid leukemia versus myelodysplastic syndrome. Oncogene 28, 2205\u20132218 (2009).","journal-title":"Oncogene"},{"key":"15220_CR51","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1038\/nmeth.2689","volume":"10","author":"M Griffith","year":"2013","unstructured":"Griffith, M. et al. DGIdb: mining the druggable genome. Nat. Methods 10, 1209\u20131210 (2013).","journal-title":"Nat. Methods"},{"key":"15220_CR52","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1101\/gad.224568.113","volume":"27","author":"M Yamada","year":"2013","unstructured":"Yamada, M. et al. ATR-Chk1-APC\/CCdh1-dependent stabilization of Cdc7-ASK (Dbf4) kinase is required for DNA lesion bypass under replication stress. Genes Dev. 27, 2459\u20132472 (2013).","journal-title":"Genes Dev."},{"key":"15220_CR53","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.tranon.2018.01.003","volume":"11","author":"Q Li","year":"2018","unstructured":"Li, Q., Xie, W., Wang, N., Li, C. & Wang, M. CDC7-dependent transcriptional regulation of RAD54L is essential for tumorigenicity and radio-resistance of glioblastoma. Transl. Oncol. 11, 300\u2013306 (2018).","journal-title":"Transl. Oncol."},{"key":"15220_CR54","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1158\/1535-7163.MCT-10-1119","volume":"10","author":"A Natoni","year":"2011","unstructured":"Natoni, A. et al. Mechanisms of action of a dual Cdc7\/Cdk9 kinase inhibitor against quiescent and proliferating CLL cells. Mol. Cancer Therapeut. 10, 1624\u20131634 (2011).","journal-title":"Mol. Cancer Therapeut."},{"key":"15220_CR55","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3892\/ol.2016.4600","volume":"12","author":"K Song","year":"2016","unstructured":"Song, K. et al. Resistance to chemotherapy is associated with altered glucose metabolism in acute myeloid leukemia. Oncol. Lett. 12, 334\u2013342 (2016).","journal-title":"Oncol. Lett."},{"key":"15220_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2014.16","volume":"3","author":"SJ Allison","year":"2014","unstructured":"Allison, S. J. et al. Identification of LDH-A as a therapeutic target for cancer cell killing via (i) p53\/NAD(H)-dependent and (ii) p53-independent pathways. Oncogenesis 3, e102 (2014).","journal-title":"Oncogenesis"},{"key":"15220_CR57","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nature13483","volume":"514","author":"MA Santos","year":"2014","unstructured":"Santos, M. A. et al. DNA-damage-induced differentiation of leukaemic cells as an anti-cancer barrier. Nature 514, 107\u2013111 (2014).","journal-title":"Nature"},{"key":"15220_CR58","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1038\/sj.onc.1206104","volume":"22","author":"BB Zeisig","year":"2003","unstructured":"Zeisig, B. B., Garcia-Cuellar, M. P., Winkler, T. H. & Slany, R. K. The oncoprotein MLL-ENL disturbs hematopoietic lineage determination and transforms a biphenotypic lymphoid\/myeloid cell. Oncogene 22, 1629\u20131637 (2003).","journal-title":"Oncogene"},{"key":"15220_CR59","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/s41556-018-0121-4","volume":"20","author":"A Giladi","year":"2018","unstructured":"Giladi, A. et al. Single-cell characterization of haematopoietic progenitors and their trajectories in homeostasis and perturbed haematopoiesis. Nat. Cell Biol. 20, 836\u2013846 (2018).","journal-title":"Nat. Cell Biol."},{"key":"15220_CR60","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.cell.2014.07.048","volume":"158","author":"YH Wang","year":"2014","unstructured":"Wang, Y. H. et al. Cell-state-specific metabolic dependency in hematopoiesis and leukemogenesis. Cell 158, 1309\u20131323 (2014).","journal-title":"Cell"},{"key":"15220_CR61","doi-asserted-by":"publisher","first-page":"40778","DOI":"10.1038\/srep40778","volume":"7","author":"AJ Massey","year":"2017","unstructured":"Massey, A. J. Modification of tumour cell metabolism modulates sensitivity to Chk1 inhibitor-induced DNA damage. Sci. Rep. 7, 40778 (2017).","journal-title":"Sci. Rep."},{"key":"15220_CR62","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/2049-3002-1-19","volume":"1","author":"J Billiard","year":"2013","unstructured":"Billiard, J. et al. Quinoline 3-sulfonamides inhibit lactate dehydrogenase A and reverse aerobic glycolysis in cancer cells. Cancer Metab. 1, 19 (2013).","journal-title":"Cancer Metab."},{"key":"15220_CR63","doi-asserted-by":"publisher","first-page":"9245","DOI":"10.1158\/0008-5472.CAN-05-1691","volume":"65","author":"SJ Horton","year":"2005","unstructured":"Horton, S. J. et al. Continuous MLL-ENL expression is necessary to establish a \u201cHox Code\u201d and maintain immortalization of hematopoietic progenitor cells. Cancer Res. 65, 9245\u20139252 (2005).","journal-title":"Cancer Res."},{"key":"15220_CR64","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.ccr.2004.10.015","volume":"6","author":"BJ Huntly","year":"2004","unstructured":"Huntly, B. J. et al. MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. Cancer Cell 6, 587\u2013596 (2004).","journal-title":"Cancer Cell"},{"key":"15220_CR65","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1093\/bioinformatics\/btn480","volume":"24","author":"AP Boyle","year":"2008","unstructured":"Boyle, A. P., Guinney, J., Crawford, C. E. & Furey, T. S. F-Seq: a feature density estimator for high-throughput sequence tags. Bioinformatics 24, 2537 (2008).","journal-title":"Bioinformatics"},{"key":"15220_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-15220-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-15220-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-15220-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T17:51:12Z","timestamp":1695923472000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-15220-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,16]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["15220"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-15220-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,16]]},"assertion":[{"value":"12 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests. L.S.C. is an AstraZeneca employee (no competing interest).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1407"}}